+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use is associated with reduced mortality in COPD

Statin use is associated with reduced mortality in COPD

European Respiratory Journal 29(2): 279-283

Patients with chronic obstructive pulmonary disease (COPD) have an increased risk of ischaemic heart disease (IHD). Statins reduce mortality and morbidity in IHD. It has been hypothesised that statin treatment is associated with reduced long-term mortality in patients with COPD. Using a retrospective cohort design, 854 consecutive patients (mean age 70.8 yrs; 51.5% female) with a diagnosis of COPD exacerbation were included in the study at discharge from a Norwegian teaching hospital. Median follow-up was 1.9 yrs, during which 333 patients died. The crude mortality rate per 1,000 person-yrs was 110 in patients treated with statins, and 191 in patients not treated with statins. After adjustment for sex, age, smoking, pulmonary function and comorbidities, the hazard ratio (HR) for statin users versus statin nonusers was 0.57 (95% confidence interval 0.38-0.87). When subdividing statin users and statin nonusers into groups according to concomitant treatment with inhaled corticosteroids (ICS) the following HRs were found: 0.75 (0.58-0.98) for ICS only; 0.69 (0.36-1.3) for statins only; and 0.39 (0.22-0.67) for the combined treatment with statin and ICS compared with no such treatment. Treatment with statins was associated with improved survival after chronic obstructive pulmonary disease exacerbation, while inhaled corticosteroids appeared to increase the survival benefit associated with statin use.

(PDF emailed within 0-6 h: $19.90)

Accession: 013017684

Download citation: RISBibTeXText

PMID: 17050558

DOI: 10.1183/09031936.00106406

Related references

Statin protection against influenza and COPD mortality. Chest 132(4): 1406; Author Reply 1406-7, 2007

Mechanism of statin-associated mortality reduction in COPD. Chest 132(4): 1409; Author Reply 1409-10, 2007

Statin Protection Against Influenza and Copd Mortality: Response. Chest 132(4): 1406-1407, 2007

Mechanism of Statin-Associated Mortality Reduction in Copd: Response. Chest 132(4): 1409-1410, 2007

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease mortality, including very elderly patients. Acc Current Journal Review 12(2): 39-40, 2003

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Primary Care Respiratory Journal 21(1): 35-40, 2012

The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-Based Cohort Study. Chest 152(3): 486-493, 2017

Statin use and reduced cancer-related mortality. New England Journal of Medicine 367(19): 1792-1802, 2012

Statin use and reduced cancer-related mortality. New England Journal of Medicine 368(6): 574-574, 2013

Statin use and reduced cancer-related mortality. New England Journal of Medicine 368(6): 574-575, 2013

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 153(4): 573-578, 2007

Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan. Tohoku Journal of Experimental Medicine 212(3): 265-273, 2007

Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease. Plos One 10(10): E0140571, 2016

Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 14(1): 1-8, 2006

An extensive English study: reduced cardiovascular mortality and morbidity by statin. Lakartidningen 98(51-52): 5846-5850, 2002